Cite
HARVARD Citation
Jiménez‐Yuste, V. et al. (2022). Safety and efficacy of long‐term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single‐arm study (STASEY). Research and practice in thrombosis and haemostasis. 6 (8), p. n/a. [Online].